Chemokine receptor expression in metastatic destination of nasopharyngeal carcinoma (NPC)

被引：0
|
作者：
Chen, CL
Ou, DL
Lin, LI
Cheng, AL
机构：
[1] Taipei Med Univ, Taipei, Taiwan
[2] Natl Taiwan Univ, Sch Med, Taipei 10764, Taiwan
来源：
MODERN PATHOLOGY | 2005年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
984
引用
收藏
页码：212A / 212A
页数：1
相关论文
共 50 条
  • [1] Chemokine receptor expression in metastatic destination of nasopharyngeal carcinoma (NPC)
    Chen, CL
    Ou, DL
    Lin, LI
    Cheng, AL
    LABORATORY INVESTIGATION, 2005, 85 : 212A - 212A
  • [2] The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma
    Hu, JY
    Deng, XY
    Bian, XW
    Li, GC
    Tong, YQ
    Li, YH
    Wang, QL
    Xin, R
    He, XJ
    Zhou, GH
    Xie, PL
    Li, YW
    Wang, JM
    Cao, Y
    CLINICAL CANCER RESEARCH, 2005, 11 (13) : 4658 - 4665
  • [3] Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy
    Ou, D-L
    Chen, C-L
    Lin, S-B
    Hsu, C-H
    Lin, L-I
    JOURNAL OF PATHOLOGY, 2006, 210 (03): : 363 - 373
  • [4] Systemic therapies for recurrent/metastatic nasopharyngeal carcinoma (RM NPC).
    Prawira, Amy
    Oosting, Sjoukje
    Chen, Tom Wei-Wu
    Saluja, Ronak
    Delos Santos, Keemo
    Wang, Lisa
    Siu, Lillian L.
    Chan, Kelvin K.
    Hansen, Aaron Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [5] Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma: pattern of expression and correlation with clinical outcome
    Wang, N
    Wu, QL
    Fang, Y
    Mai, HQ
    Zeng, MS
    Shen, GP
    Hou, JH
    Zeng, YX
    JOURNAL OF TRANSLATIONAL MEDICINE, 2005, 3 (1)
  • [6] Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma: pattern of expression and correlation with clinical outcome
    Na Wang
    Qiu-Liang Wu
    Yan Fang
    Hai-Qiang Mai
    Mu-Sheng Zeng
    Guo-Ping Shen
    Jing-Hui Hou
    Yi-Xin Zeng
    Journal of Translational Medicine, 3
  • [7] NASOPHARYNGEAL CARCINOMA (NPC) IN ESKIMOS
    HANSEN, JPH
    NIELSEN, NH
    ANTICANCER RESEARCH, 1982, 2 (06) : 326 - 326
  • [8] CHEMOTHERAPY OF NASOPHARYNGEAL CARCINOMA (NPC)
    BERTRAM, G
    MOHR, R
    WICKRAMANAYAKE, P
    ARCHIVES OF OTO-RHINO-LARYNGOLOGY-ARCHIV FUR OHREN-NASEN-UND KEHLKOPFHEILKUNDE, 1985, 241 (02): : 139 - 139
  • [9] A phase II study of axitinib in patients with recurrent or metastatic nasopharyngeal carcinoma (NPC).
    Hui, Edwin Pun
    Ma, Brigette
    Mo, Frankie
    Kam, Michael K. M.
    Chan, Stephen Lam
    Loong, Herbert H. F.
    Ho, Rosalie
    Leung, Sing Fai
    King, Ann Dorothy
    Wang, Ki
    Ahuja, Anil Tejbhan
    Chan, Charles
    Hui, Connie W. C.
    Wong, Chi Hang
    Chan, Anthony T. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [10] Chemokine and Chemokine Receptor Profiles in Metastatic Salivary Adenoid Cystic Carcinoma
    Mays, Ashley C.
    Feng, Xin
    Browne, James D.
    Sullivan, Christopher A.
    ANTICANCER RESEARCH, 2016, 36 (08) : 4013 - 4018
12345